Covered recipient · General Payments record
NANCY W FINNERTY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,239.57
- Reported across 278 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.59 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $84.18 | 5 |
| Lilly USA, LLC | $64.91 | 4 |
| Exact Sciences Corporation | $59.79 | 4 |
| GlaxoSmithKline, LLC. | $54.36 | 3 |
| ABBVIE INC. | $53.84 | 2 |
| Novo Nordisk AS | $47.52 | 3 |
| PFIZER INC. | $47.23 | 2 |
| Acerta Pharma LLC | $30.16 | 2 |
| DEXCOM, INC. | $24.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.30 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103730433 | CMS |
| ABBVIE INC. | $21.54 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103730435 | CMS |
| Amgen Inc. | $14.48 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115624068 | CMS |
| Amgen Inc. | $17.46 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117553567 | CMS |
| Amgen Inc. | $17.17 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117553569 | CMS |
| Amgen Inc. | $17.28 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117553571 | CMS |
| Amgen Inc. | $17.79 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115624076 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.41 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104527422 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.75 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105798626 | CMS |
| Dexcom, Inc. | $24.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153324697 | CMS |
| Exact Sciences Corporation | $15.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657647 | CMS |
| Exact Sciences Corporation | $14.72 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657651 | CMS |
| Exact Sciences Corporation | $14.89 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657657 | CMS |
| Exact Sciences Corporation | $14.38 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657663 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116687903 | CMS |
| GlaxoSmithKline, LLC. | $19.89 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116480095 | CMS |
| GlaxoSmithKline, LLC. | $20.02 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116680557 | CMS |
| Lilly USA, LLC | $17.61 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263697 | CMS |
| Lilly USA, LLC | $14.79 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135232809 | CMS |
| Lilly USA, LLC | $17.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135175473 | CMS |
| Lilly USA, LLC | $15.46 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135175475 | CMS |
| Novo Nordisk Inc | $13.32 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097452471 | CMS |
| Novo Nordisk Inc | $18.55 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096660084 | CMS |
| Novo Nordisk Inc | $15.65 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096669623 | CMS |
| PFIZER INC. | $18.11 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132064188 | CMS |
| PFIZER INC. | $29.12 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132058796 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.